The concept of CRO continues to rise, and Nanmo Bio has hit a 20cm limit up.

The CRO concept continues to rise during the session, with Nanmo Bio hitting a 20% limit up. Previously, Boji Medical also hit a 20% limit up, while Wanbang Medicine rose by 18%. Nearshore Protein, Haoyuan Medical, Ruizhihua Medical, Aopumai, and Bai Aosaitu had significant increases as well.